Sumathy Mathialagan
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 29
- Drug Transport and Resistance Mechanisms 25
- Cytokine Signaling Pathways and Interactions 4
-
- Pharmacological Effects and Toxicity Studies 10
- Co-authors
- Manthena V. S. Varma (17 shared papers)Nandini Kishore (9 shared papers)A. David Rodrigues (11 shared papers)Catherine S. Tripp (6 shared papers)Bo Feng (3 shared papers)David A. Tess (5 shared papers)Sheri L. Bonar (7 shared papers)Yi‐An Bi (11 shared papers)
- Journals
- Drug Metabolism and Disposition (6 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)Clinical Pharmacology & Therapeutics (5 papers)Journal of Biological Chemistry (4 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesFinlandChina
In The Last Decade
Sumathy Mathialagan
41 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Pharmacology 288
- Oncology 640
- Cancer Research 307
- Pediatrics, Perinatology and Child Health 255
- Immunology 263
Countries citing papers authored by Sumathy Mathialagan
This map shows the geographic impact of Sumathy Mathialagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumathy Mathialagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumathy Mathialagan more than expected).
Fields of papers citing papers by Sumathy Mathialagan
This network shows the impact of papers produced by Sumathy Mathialagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumathy Mathialagan. The network helps show where Sumathy Mathialagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumathy Mathialagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 253 | |
| 2 | 2002 | 119 | |
| 3 | 2017 | 107 | |
| 4 | 2019 | 68 | |
| 5 | 2009 | 58 | |
| 6 | 2010 | 56 | |
| 7 | 2017 | 51 | |
| 8 | 2018 | 48 | |
| 9 | 2018 | 44 | |
| 10 | 2017 | 40 | |
| 11 | 2020 | 39 | |
| 12 | 2010 | 38 | |
| 13 | 2020 | 37 | |
| 14 | 2020 | 33 | |
| 15 | 2018 | 33 | |
| 16 | 2020 | 31 | |
| 17 | 2009 | 29 | |
| 18 | 2005 | 28 | |
| 19 | 2021 | 28 | |
| 20 | 2020 | 28 |
About Sumathy Mathialagan
Sumathy Mathialagan is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Cancer Research, Pharmacology and Immunology, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (25 papers), NF-κB Signaling Pathways (10 papers), Pharmacological Effects and Toxicity Studies (10 papers), Pharmacogenetics and Drug Metabolism (8 papers), Immune Response and Inflammation (8 papers), Metabolism and Genetic Disorders (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Pharmacology (288 citations), Oncology (640 citations), Cancer Research (307 citations), Pediatrics, Perinatology and Child Health (255 citations) and Immunology (263 citations). Sumathy Mathialagan has collaborated with scholars based in United States, Finland and China. Frequent co-authors include Manthena V. S. Varma, Nandini Kishore, A. David Rodrigues, Catherine S. Tripp, Bo Feng, David A. Tess, Sheri L. Bonar, Yi‐An Bi, Julia A. Guzova and Chester Costales. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics, Journal of Biological Chemistry and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.